Neonatal screening

Screening and prevention of neonatal glucose 6-phosphate dehydrogenase deficiency in Guangzhou, China

J. Jiang, Li, B., Cao, W., Jiang, X., Jia, X., Chen, Q., and Wu, J., Screening and prevention of neonatal glucose 6-phosphate dehydrogenase deficiency in Guangzhou, China, vol. 13, pp. 4272-4279, 2014.

We aimed to summarize the results of screening protocol and prevention of neonatal glucose 6-phosphate dehydrogenase (G6PD) deficiency during a 22-year-long period to provide a basis of reference for the screening of this disease. About 1,705,569 newborn subjects in Guangzhou City were screened for this deficiency. Specimens were collected according to the conventional method of specimen acquisition for “newborn dried bloodspot screening”, preserved, and inspected. The specimens were studied with fluorescent spot test and quantitative fluorescence assay.

Neonatal detection of Turner syndrome by real-time PCR gene quantification of the ARSE and MAGEH1 genes

S. C. Corrêa, Rocha, M. N., Richeti, F., Kochi, C., Lima, L. A. Silva e, Magalhães, M., and Longui, C. A., Neonatal detection of Turner syndrome by real-time PCR gene quantification of the ARSE and MAGEH1 genes, vol. 13, pp. 9068-9076, 2014.

Turner syndrome (TS) is characterized by the presence of one full X chromosome and total or partial deletion of the second sex chromosome. Diagnosis of TS is often delayed, resulting in inappropriate treatment. Early diagnosis of TS using a neonatal screening test may improve preventive measures and treatment, thus improving patient quality of life. The goal of this study was to standardize a neonatal TS screening algorithm. Two study genes (ARSE and MAGEH1) and 1 normalizing gene (HBB) were used to detect the second X chromosome.

Three-dimensional visualization of human hemoglobin phenotypes with HPLC

L. M. Storti-Melo, Mangonaro, P. H., Valêncio, C. R., Valêncio, C. R., C. Junior, T., and Domingos, C. R. B., Three-dimensional visualization of human hemoglobin phenotypes with HPLC, vol. 8, pp. 354-363, 2009.

Hemoglobinopathies were included in the Brazilian Neonatal Screening Program on June 6, 2001. Automated high-performance liquid chromatography (HPLC) was indicated as one of the diagnostic methods. The amount of information generated by these systems is immense, and the behavior of groups cannot always be observed in individual analyses. Three-dimensional (3-D) visualization techniques can be applied to extract this information, for extracting patterns, trends or relations from the results stored in databases.

A three-step molecular protocol employing DNA obtained from dried blood spots for neonatal screening for 45,X Turner syndrome

M. Neves Rocha, Melo, M. Rezende, Longui, C. Alberto, de Oliveira, D. Vilariço, Figueiredo, C. Costa, and Pacchi, P. Roberto, A three-step molecular protocol employing DNA obtained from dried blood spots for neonatal screening for 45,X Turner syndrome, vol. 4, pp. 749-754, 2005.

Turner syndrome (TS) is one of the most common human chromosomal abnormalities; it is characterized by the presence of one normal X chromosome and the complete or partial loss of the second X chromosome. The early recognition of TS patients allows for adequate therapy for short stature and pubertal sex steroid substitution. We developed a cost-effective molecular diagnostic tool that can be used to identify 45,X TS patients from dried blood spots, for possible use in neonatal screening for TS.

Subscribe to Neonatal screening